1. Impact of quality improvement initiatives to improve CKD referral patterns: a systematic review protocol
- Author
-
Anukul Ghimire, Naima Sultana, Feng Ye, Laura N Hamonic, Allan K Grill, Alexander Singer, Ayub Akbari, Branko Braam, David Collister, Kailash Jindal, Mark Courtney, Nikhil Shah, Paul E Ronksley, Sabin Shurraw, Kenneth Scott Brimble, Scott Klarenbach, Sophia Chou, Soroush Shojai, Vinay Deved, Andrew Wong, Ikechi Okpechi, and A K Bello
- Subjects
Adult ,Male ,Humans ,Female ,General Medicine ,Renal Insufficiency, Chronic ,Quality Improvement ,Referral and Consultation ,Systematic Reviews as Topic - Abstract
IntroductionChronic kidney disease (CKD) is a global-health problem. A significant proportion of referrals to nephrologists for CKD management are early and guideline-discordant, which may lead to an excess number of referrals and increased wait-times. Various initiatives have been tested to increase the proportion of guideline-concordant referrals and decrease wait times. This paper describes the protocol for a systematic review to study the impacts of quality improvement initiatives aimed at decreasing the number of non-guideline concordant referrals, increasing the number of guideline-concordant referrals and decreasing wait times for patients to access a nephrologist.Methods and analysisWe developed this protocol by using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols (2015). We will search the following empirical electronic databases: MEDLINE, Embase, Cochrane Library, CINAHL, Web of Science, PsycINFO and grey literature for studies designed to improve guideline-concordant referrals or to reduce unnecessary referrals of patients with CKD from primary care to nephrology. Our search will include all studies published from database inception to April 2021 with no language restrictions. The studies will be limited to referrals for adult patients to nephrologists. Referrals of patients with CKD from non-nephrology specialists (eg, general internal medicine) will be excluded.Ethics and disseminationEthics approval will not be required, as we will analyse data from studies that have already been published and are publicly accessible. We will share our findings using traditional approaches, including scientific presentations, open access peer-reviewed platforms, and appropriate government and public health agencies.PROSPERO registration numberCRD42021247756.
- Published
- 2022
- Full Text
- View/download PDF